IISER-Tirupati-India

October 21, 2023

IISER-Tirupati-India # AnthraFelix: Novel probiotic therapeutic for Irritable Bowel Syndrome-Diarrhoea Predominant(IBS-D). # IBS-D is a prevalent Functional Gastro-Intestinal Disorder (FGID), affecting approximately 11.2% of the global population and 7.5% of Indians. Stress, unhealthy diet, disrupted gut microbiota, and genetic factors contribute to this syndrome. The rise of urbanization and globalization in developing nations has significantly impacted lifestyle, resulting in disturbed sleep, altered diet patterns, and adverse health effects. IBS-D symptoms include diarrhoea, bloating, disturbed sleep, and nausea. ...